MLM Companies
Immunotec Review 2026
Patented glutathione supplement MLM since 1996
Residual Income Rating
2.1 / 5Last updated:
January 15, 2026What is Immunotec?
Nutritional supplements focused on glutathione enhancement through Immunocal — a patented whey protein isolate. Based on research by Dr. Gustavo Bounous. Products marketed for immune health and cellular function support.
Pros
- 29 years in business — patented Immunocal
- Per-customer residual ~$8-12/mo on subscriptions
- No commission for recruiting alone
- Scientific research backing
Cons
- Low per-customer residual (~$8-12/mo)
- Monthly $45+ to stay active
- DSSRC concerns about income claims
- Single product focus limits options
Rating Breakdown
Residual Income
2.1 / 5Simplicity
2.0 / 5Transparency
2.0 / 5Community & Support
2.5 / 5Value for Money
3.0 / 5Overall Rating
2.1 / 5Frequently Asked Questions About Immunotec
Does Immunotec work?
Immunocal is based on legitimate glutathione research by Dr. Gustavo Bounous. The product is patented and may support glutathione levels, though specific health claims are not FDA-evaluated. The company has operated since 1996.
How much do Immunotec consultants earn?
Earning potential depends on sales volume and team development. The company pays commissions only on product sales, not recruiting alone. Monthly costs to maintain active status are $45+.
Is Immunotec different from other supplement MLMs?
Immunotec focuses on a single patented flagship product (Immunocal) based on scientific research. The company has operated since 1996 in Canada and internationally. The focused product line differs from MLMs with broad supplement catalogs.
Quick Facts
Founded1996
HeadquartersQuebec, Canada
Business ModelMulti-level marketing
Key ProductImmunocal (glutathione)
Startup Cost$45 Welcome Kit
📖 FREE EBOOK
The Residual Income Shortcut
Tired of MLM math that never adds up? This free guide shows the model that replaced a 600-person team with 24 customers.
No credit card required
Related Companies
Report an Inaccuracy
Spot something out of date or wrong on this page? Tell us and we will check it.